Breaking News

Kincell Bio Expands Research Triangle Park, North Carolina Facility

New infrastructure aims to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval life cycle management.

Author Image

By: Charlie Sternberg

Associate Editor

Kincell Bio, a contract development and manufacturing organization (CDMO) supporting autologous and allogeneic cell therapy programs, is expanding its Research Triangle Park (RTP), North Carolina facility to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval life cycle management. The RTP facility serves as Kincell Bio’s center of excellence for pivotal supply, commercialization, and commercial manufacturing, complementin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters